Receive The Newest Study Notifications

Key Points Immuron to develop U.S. registration dossier for IMM-124E for Travelers’ Diarrhea Company anticipates significant inflection in sales with successful FDA registration of IMM-124E Company to pursue rapid path for clinical development of IMM-124E...

Findings show roluperidone increases release and gene expression of BDNF, as well as release of GDNF Data presented at 2019 Congress of the Schizophrenia International Research Society Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical...

Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the biotechnology industry as well. Usually regulations increase costs and create hurdles for these companies, but in the...

Cirius Therapeutics announced today that positive results from an interim analysis of exploratory endpoints from the EMMINENCE trial, its ongoing Phase 2b clinical trial evaluating MSDC-0602K in 402 patients diagnosed with non-alcoholic steatohepatitis (NASH) with...

Billing and reimbursement are key to the bottom line success of trials. Optimize the reimbursement with best practices. Clinical Trial Billing Documentation Best Practices: Optimize Reimbursement **A CenterWatch Webinar** Wednesday, April 24, 2019, 11:00 a.m. - 12:30...

GlycoMimetics, Inc. (NASDAQ: GLYC) today announced plans to initiate a clinical trial of GMI-1359 in breast cancer patients whose tumors have spread to bone. GMI-1359 is a dual function antagonist that targets both E-selectin and CXCR4, both of which are involved in...

Pivotal Phase 3 study is evaluating efficacy and safety of investigational regenerative skin tissue in adults with deep partial-thickness burns Mallinckrodt plc(NYSE: MNK), a leading global specialty pharmaceutical company, today announced that Stratatech,...

Innoplexus leveraged a proprietary domain-specific AI based model trained on millions of data points to assess Biogen's Alzheimer's drug On March 21st, 2019, Biogen's stock declined sharply, showing a decrease of 29%, resulting in losses to the tune of $18Bn for...

SC Liver Research Consortium and Perspectum Diagnostics develop major US clinical network This will provide clinical trial services supporting drug development for liver disorders SC Liver Research Consortium (SC Liver) and Perspectum Diagnostics have developed a...

Patient recruitment is essential to the clinical trial process. Without patients to participate, a trial can't become a reality. Sometimes, sites take on a study and lack the planning or resources to enroll an adequate amount of patients. Clinical trial recruitment...

Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of single-administration Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)...

Peloton Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing first-in-class oral medicines for cancer and other serious conditions, announced the completion of patient enrollment in a Phase 2 clinical trial evaluating the efficacy and safety of its...

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announces that it has strengthened its intellectual property rights for its Phase 2-ready product FR104, a monoclonal antibody antagonist of CD28, through the granting of a patent by the Canadian Intellectual...

Primary safety endpoint met as FX-322 was well tolerated Preliminary clinical data suggests improvement on measures of hearing function Company now planning Phase 2 Study to commence later this year WOBURN, Mass.--(BUSINESS WIRE)-- Frequency Therapeutics, a clinical...

VeraSci recently welcomed Mark Skeen, MD as Senior Medical Scientist. In this role Dr. Skeen will provide disease state expertise for a broad range of neurologic diseases as well as the perspective of the clinician conducting clinical trials. As part of his role at...

LSK BioPharma (or "LSKB"), a US-based biopharmaceutical firm and Jiangsu Hengrui Medicine, Co., Ltd. (SHA:600276, or "Hengrui"), one of the largest and most innovative fully-integrated biopharmaceutical companies based in China, today announced that the Companies have...

Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced it has completed the...

Alignment with FDA on a single, pivotal, 12-week, placebo-controlled, Phase 3 clinical trial to initiate in the second half of 2019 Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the successful completion of End-of-Phase 2 interactions with the U.S. Food and...

Being chosen as the physical location for a clinical trial is an exciting endeavor. You'll be responsible for the reputation of the trial, patient interaction, and even have the opportunity to foster relationships with the research sponsor. Clinical trial...

Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment milestone in its continuing Phase II Clinical Trial for critical limb ischemia (“CLI”). Enrollment rates have increased...